Jump to main content

How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants?Discussion and suggestions from nephrologists

Icons representing 記事
The cover of this title could differ from library to library. Link to Help Page

How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants?Discussion and suggestions from nephrologists

Persistent ID (NDL)
info:ndljp/pid/11659256
Material type
記事
Author
Aya Imafukuほか
Publisher
Springer Nature
Publication date
2020-03-30
Material Format
Digital
Journal name
Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology 24(8)
Publication Page
-
View Details

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある電子書籍・電子雑誌の提供元Webサイトなどから、本文を自由に閲覧できる場合があります。

Detailed bibliographic record

Summary, etc.:

Both thin basement membrane nephropathy (TBMN) and autosomal dominant Alport syndrome (ADAS) are types of hereditary nephritis resulting from heterozy...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    Digital
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
記事
Author/Editor
Aya Imafuku
Kandai Nozu
Naoki Sawa
Publication, Distribution, etc.
Publication Date
2020-03-30
Publication Date (W3CDTF)
2020-03-30
Periodical title
Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology
No. or year of volume/issue
24(8)
Volume
24(8)
ISSN (Periodical Title)
1437-7799
ISSN-L (Periodical Title)
1437-7799
Text Language Code
eng
Persistent ID (NDL)
info:ndljp/pid/11659256
Collection (Materials For Handicapped People:1)
Collection (particular)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
Acquisition Basis
オンライン資料収集制度
Date Accepted (W3CDTF)
2021-04-07T03:01:22+09:00
Date Captured (W3CDTF)
2021-03-11
Format (IMT)
application/pdf
Access Restrictions
国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service
図書館・個人送信対象外
Availability of remote photoduplication service
Periodical Title (Persistent ID (NDL))
info:ndljp/pid/11659255
Data Provider (Database)
国立国会図書館 : 国立国会図書館デジタルコレクション

Digital

Summary, etc.
Both thin basement membrane nephropathy (TBMN) and autosomal dominant Alport syndrome (ADAS) are types of hereditary nephritis resulting from heterozygous mutations in COL4A3 or COL4A4 genes. Although TBMN is characterized by hematuria and thinning of the glomerular basement membrane (GBM) with excellent renal prognosis, some patients develop end-stage renal disease (ESRD) later in life. In contrast, although AS is characterized by progressive nephropathy with lamellation of the GBM, there are some patients diagnosed with ADAS from a family history of ESRD but who only suffer from hematuria with GBM thinning. These findings indicate a limitation in distinction between TBMN and ADAS. Diagnosis of AS is significant because it facilitates careful follow-up and early treatment, whereas diagnosis of TBMN can underestimate the risk of ESRD. However, some experts are against using the term ADAS as the phenotypes of heterozygous variants vary from no urinary abnormality to ESRD, even between family members with the same mutations, indicating that unknown secondary factors may play a large role in the disease severity. These diagnostic difficulties result in significant confusion in clinical settings. Moreover, recent studies revealed that the number of patients with chronic kidney disease caused by these gene mutations is far higher than previously thought. The aim of this article is to review differing opinions regarding the diagnosis of heterozygous COL4A3 or COL4A4 variants, and to highlight the importance for nephrologists to recognize this disease, and the importance of the need to reclassify this disease to minimize the current confusion.
論文
Access Restrictions
インターネット公開
Is Referenced By
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
VI.CKDに潜在する遺伝性腎疾患の重要性
Data Provider (Database)
国立情報学研究所 : CiNii Research
Original Data Provider (Database)
学術機関リポジトリデータベース
雑誌記事索引データベース
Crossref
CiNii Articles
Crossref
Crossref
Bibliographic ID (NDL)
11659256
NAID
120006891160